Anhui Anke BioTech Group Cash Flow Quality Index
Anhui Anke BioTech Group cash flow quality index. Anhui Anke BioTech Group (300009) has a Cash Flow Quality Index of 1.30x as of September 2025. Operating cash flow of CN¥240.51 Million exceeds net income of CN¥184.97 Million, indicating high earnings quality where cash backs reported profits. See Anhui Anke BioTech Group leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Anhui Anke BioTech Group (2006–2025)
Cash flow quality index of Anhui Anke BioTech Group from 2006 to 2025. Historical Cash Flow Quality Index for Anhui Anke BioTech Group across 20 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Anhui Anke BioTech Group debt service capacity to assess how comfortably operating cash covers total debt obligations.
Anhui Anke BioTech Group Cash Flow Quality Index by Year (2006–2025)
Anhui Anke BioTech Group cash flow quality index by year from 2006 to 2025. Year-by-year earnings quality comparison for Anhui Anke BioTech Group. For the full cash flow conversion analysis, see Anhui Anke BioTech Group cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.17x | CN¥863.22 Million | CN¥735.19 Million | ▲ +22.6% |
| 2024 | 0.96x | CN¥685.37 Million | CN¥715.84 Million | ▼ -14.9% |
| 2023 | 1.12x | CN¥952.97 Million | CN¥847.23 Million | ▲ +18.7% |
| 2022 | 0.95x | CN¥698.98 Million | CN¥737.72 Million | ▼ -67.5% |
| 2021 | 2.91x | CN¥592.17 Million | CN¥203.39 Million | ▲ +124.9% |
| 2020 | 1.29x | CN¥464.80 Million | CN¥358.96 Million | ▼ -51.6% |
| 2019 | 2.68x | CN¥295.63 Million | CN¥110.40 Million | ▲ +146.6% |
| 2018 | 1.09x | CN¥287.49 Million | CN¥264.75 Million | ▲ +7.5% |
| 2017 | 1.01x | CN¥280.63 Million | CN¥277.74 Million | ▼ -22.5% |
| 2016 | 1.30x | CN¥258.01 Million | CN¥197.87 Million | ▲ +49.6% |
| 2015 | 0.87x | CN¥118.73 Million | CN¥136.25 Million | ▼ -11.9% |
| 2014 | 0.99x | CN¥108.68 Million | CN¥109.85 Million | ▲ +67.1% |
| 2013 | 0.59x | CN¥53.21 Million | CN¥89.87 Million | ▼ -18.6% |
| 2012 | 0.73x | CN¥53.80 Million | CN¥73.95 Million | ▲ +532.1% |
| 2011 | 0.12x | CN¥7.18 Million | CN¥62.38 Million | ▼ -87.5% |
| 2010 | 0.92x | CN¥47.43 Million | CN¥51.64 Million | ▲ +5.8% |
| 2009 | 0.87x | CN¥38.67 Million | CN¥44.57 Million | ▲ +20.2% |
| 2008 | 0.72x | CN¥26.04 Million | CN¥36.06 Million | ▼ -55.8% |
| 2007 | 1.63x | CN¥35.10 Million | CN¥21.50 Million | ▼ -18.3% |
| 2006 | 2.00x | CN¥29.66 Million | CN¥14.84 Million | — |